Reuters logo
BRIEF-Shandong Jincheng Pharma gets approval for asset acquisition plan, share trade to resume
November 30, 2016 / 8:55 AM / a year ago

BRIEF-Shandong Jincheng Pharma gets approval for asset acquisition plan, share trade to resume

Nov 30 (Reuters) - Shandong Jincheng Pharmaceutical Co Ltd

* Says it gets securities regulator’s approval for asset acquisition plan, share trade to resume on Dec 1

Source text in Chinese: bit.ly/2fKy1QX

Further company coverage: (Reporting by Beijing newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below